Stocktoria
Medirom Healthcare Technologies Inc. MRM
Nasdaq · stock · Services-Personal Services · website · IPO 2020-12-29
Medirom Healthcare Technologies Inc. financials (annual)
Bars are annual figures from 2019 to 2024; red bars are negative (a loss or cash outflow).
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue | $8.3B | $6.8B | $7.0B | $5.4B | $3.3B | $3.9B |
| Gross profit | $2.2B | $1.6B | $1.9B | — | — | — |
| SG&A expense | $2.2B | $2.0B | $1.8B | $1.8B | $1.1B | $871.9M |
| Operating income | -$18.1M | -$391.6M | $97.0M | -$470.6M | -$746.1M | $34.4M |
| Interest expense | — | $36.9M | $9.8M | $11.9M | $13.2M | $13.6M |
| Income tax | -$90.5M | -$94.4M | $30.8M | $576.2M | -$87.5M | $16.0M |
| Net income | $148.8M | $115.4M | $149.0M | -$990.7M | -$539.2M | $17.3M |
| EPS (diluted) | $28.52 | $22.34 | $27.23 | $-203.13 | $-133.97 | $4.06 |
| Operating cash flow | -$1.3B | -$631.7M | -$685.7M | -$557.2M | -$366.4M | $7.9M |
| Free cash flow | -$1.4B | -$767.6M | -$806.4M | -$652.9M | -$440.0M | $464,000 |
| Cash & equivalents | $2.1M | $755,000 | $4.6M | $370.6M | $1.4B | $513.6M |
| Inventory | $151.6M | $140.0M | $114.1M | $18.7M | $8.0M | $5.5M |
| Total assets | $8.1B | $6.8B | $6.7B | $5.8B | $5.7B | $4.8B |
| Total liabilities | $6.9B | $6.6B | $6.8B | $6.0B | $5.2B | — |
| Shareholders' equity | $987.9M | $216.0M | -$59.4M | -$208.3M | $491.3M | $600.1M |
Growth · year-over-year · Revenue CAGR 16.3%
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Revenue growth | +21.5% | -1.8% | +28.5% | +61.9% | -14.5% | — |
| Net income growth | +28.9% | -22.5% | — | — | -3210.3% | — |
| EPS growth | +27.7% | -18.0% | — | — | -3399.8% | — |
| Free cash flow growth | — | — | — | — | -94922.4% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · US · as of 2024-12-31. Facts plus Stocktoria's own computed scores — not investment advice.